Annual report [Section 13 and 15(d), not S-K Item 405]

Note 2 - Summary of Significant Accounting Policies - Schedule of Fair Value Instruments (Details)

v3.25.0.1
Note 2 - Summary of Significant Accounting Policies - Schedule of Fair Value Instruments (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Reported Value Measurement [Member]    
Cash and Cash Equivalents $ 0 $ 0
Accounts Receivable 143 454
Notes Receivable 188 645
Investments 0 0
Accounts Payable & Accrued Liabilities 7,391 16,596
Notes Payable 2,967 29,078
Derivative Liability 0 0
Estimate of Fair Value Measurement [Member]    
Cash and Cash Equivalents 1,040 416
Accounts Receivable 0 0
Notes Receivable 0 0
Investments 0 2,067
Accounts Payable & Accrued Liabilities 0 0
Notes Payable 0 0
Derivative Liability $ 4,102 $ 0